Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (9152)	10/18/2000 11:19:14 AM
From: scaram(o)uche	Respond to of 9262

I'm just trading tick-by-ticks in these companies that are acknowledged bargains but which also are prime tax-sell territory. One can hit them 3X per day, for about 5% per round trip. This year has been a biotech freak's dream. Capitalizations are spread out in a completely irrational fashion. The end of February was nuts, but you had a gaggle of related technologies which had run out in front, a clear class of "haves" which could be differentiated from the "have nots". But now? It's heaven..... there are massively over valued stocks, and CNBC's Insana et al. are scoffing at biotech as a safe haven. This just leads to more and more pressure building under those issues that ARE true safe havens. Position trades in biotech..... they've been sensational since the end of February, and they're gorgeous now.